PDTC

AcronymDefinition
PDTCPoorly Differentiated Thyroid Carcinoma (cancer)
PDTCpyrollidine dithiocarbamate
PDTCPopulation Dependent Transmission Control (computer networking)
PDTCProfessional Development Training Center
PDTCpyridine-2,6-dithiocarboxylic acid
PDTCPrinceton Dog Training Club (New Jersey; est. 1952)
PDTCPhiladelphia Dog Training Club
PDTCProfessional Development Technology Center (Knoxville, TN)
References in periodicals archive ?
In this experimental study, we aimed to investigate whether PDTC is protective over nephropathy by inhibition of NF-[kappa]B and iNOS formation and prevention of oxidative stress in streptozotocin-induced diabetic rats.
To further investigate the mechanism of PC-induced NO and TNF-[alpha] production, we examined the ability of nuclear factor-[kappa]B (NF-[kappa]B) inhibitor such as pyrrolidine dithiocarbamate (PDTC) (13) to block PC-induced effect.
The study opens with a discussion on the melting and the crystallization behavior of PCL and PDTC blocks in blends.
PDTC was defined on the basis of the Turin proposal [17]: (1) presence of a solid/trabecular/insular pattern of growth, (2) absence of the conventional nuclear features of papillary carcinoma, and (3) presence of at least one of the following features: convoluted nuclei, mitotic activity > 3 x 10 HPF, and tumor necrosis.
For the comparative studies of other NF-[kappa]B inhibitors, this activation of gelatinolysis was significantly inhibited by about 38.8 [+ or -] 6.6% by PMC (50 [micro]M) but not by PDTC (100 [micro]M) (lanes 5 and 6).
Thus we further examined the effect of PDTC, an inhibitor of NF-KB, and siRNA for p65 on CTGF levels in cultured rat cardiac fibroblasts.
In a study performed at Memorial Sloan-Kettering Cancer Center, we defined PDTC on the basis of the presence of necrosis and/or a high mitotic rate, irrespective of growth pattern and cell type (Figure 8).
Reagents: MTT (3-(4,5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolium-bromide), PAF (1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine), TPS (trypsin), NAC, PDTC (pyrrolidine dithiocarbamate) and monoclonal antibody against PCNA (proliferating cell nuclear antigen) were purchased from Sigma Corporation, St.Louis, USA.
Activation of the Wnt/[beta]-catenin signaling is often caused by activating mutations of CTNNB1 (which encodes [beta]-catenin) in thyroid cancer, particularly in poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid carcinoma (ATC) [42, 43].